Sin financiación2.771 JCR (2017) Q2, 56/128 Cardiac and Cardiovascular Systems, 111/261 Pharmacology and PharmacyUE
Abstract: The possible therapeutic role of melatonin in the pathophysiology of coronary artery disor...
Melatonin is a promising cardioprotective agent. Its increase during the night is associated with he...
Ischemia-reperfusion injury is a common problem in the age of interventional cardiology; it is prima...
Sin financiación4.638 JCR (2015) Q1, 20/124 Cardiac and Cardiovascular SystemsUE
Sin financiación6.290 JCR (2017) Q1, 16/128 Cardiac and Cardiovascular SystemsUE
Sin financiación2.756 JCR (2018) Q2, 60/136 Cardiac & Cardiovascular Systems; Q3, 70/136 Medicine, R...
Melatonin, an endocrine product of the pineal gland, is formed predominantly during the nighttime. L...
Cardiovascular diseases (CVDs) are the leading global cause of mortality and disability, tending to ...
The dose- and time dependence of melatonin and the effective window of melatonin administration were...
This brief review considers some of the cardiac diseases and conditions where free radicals and rela...
This brief review considers some of the cardiac diseases and conditions where free radicals and rela...
Aims. Myocardial reperfusion damage after severe ischemia was an important issue during a clinical p...
Melatonin, an endogenously produced hormone, might potentially limit the ischemia reperfusion injury...
BACKGROUND: Myocardial ischemia/reperfusion injury associated with coronary artery bypass graft (CAB...
Heart failure is a multifactorial clinical syndrome characterized by the inability of the heart to p...
Abstract: The possible therapeutic role of melatonin in the pathophysiology of coronary artery disor...
Melatonin is a promising cardioprotective agent. Its increase during the night is associated with he...
Ischemia-reperfusion injury is a common problem in the age of interventional cardiology; it is prima...
Sin financiación4.638 JCR (2015) Q1, 20/124 Cardiac and Cardiovascular SystemsUE
Sin financiación6.290 JCR (2017) Q1, 16/128 Cardiac and Cardiovascular SystemsUE
Sin financiación2.756 JCR (2018) Q2, 60/136 Cardiac & Cardiovascular Systems; Q3, 70/136 Medicine, R...
Melatonin, an endocrine product of the pineal gland, is formed predominantly during the nighttime. L...
Cardiovascular diseases (CVDs) are the leading global cause of mortality and disability, tending to ...
The dose- and time dependence of melatonin and the effective window of melatonin administration were...
This brief review considers some of the cardiac diseases and conditions where free radicals and rela...
This brief review considers some of the cardiac diseases and conditions where free radicals and rela...
Aims. Myocardial reperfusion damage after severe ischemia was an important issue during a clinical p...
Melatonin, an endogenously produced hormone, might potentially limit the ischemia reperfusion injury...
BACKGROUND: Myocardial ischemia/reperfusion injury associated with coronary artery bypass graft (CAB...
Heart failure is a multifactorial clinical syndrome characterized by the inability of the heart to p...
Abstract: The possible therapeutic role of melatonin in the pathophysiology of coronary artery disor...
Melatonin is a promising cardioprotective agent. Its increase during the night is associated with he...
Ischemia-reperfusion injury is a common problem in the age of interventional cardiology; it is prima...